Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

The Surviving Sepsis Campaign Creates COVID-19 Guideline

By Sean Hickey, MD; and Melissa Villars, MD, MPH | on November 23, 2021 | 0 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
shutterstock.com
Table 1: SSC COVID-19 Guidelines

You Might Also Like
  • Opinion: How the Surviving Sepsis Campaign Got Almost Everything Wrong
  • ACEP Endorses Latest Surviving Sepsis Campaign Recommendations
  • ACEP Sepsis Task Force Report Delivers Key Insights
Explore This Issue
ACEP Now: Vol 40 – No 11 – November 2021

(click for larger image) Table 1: SSC COVID-19 Guidelines

ARDS = acute respiratory distress syndrome, RCT = randomized controlled trial, VTE = venous thromboembolism.

Reprinted with permission from Crit Care Med. 2021;49(3):e219-e234.

* Editor’s note: The data regarding COVID changes rapidly. A large RCT, the C3PO trial, showed negative effects of convalescent plasma in August 2021.

The guideline utilizes “we recommend” for strong recommendations and “we suggest” for weak recommendations. Ultimately three new recommendations and six updated recommendations were added to the prior SSC COVID-19 guidelines. New and updated recommendations will be forthcoming as the COVID-19 evidence base grows in accordance with the above stated living guideline methodology.

Briefly, the guideline recommends against the use of hydroxychloroquine and therapeutic anticoagulation; suggests against convalescent plasma; recommends the use of pharmacologic venous thromboembolism prophylaxis and corticosteroids, suggesting dexamethasone as the corticosteroid choice; and suggests remdesivir in severe COVID-19 patients not needing mechanical ventilation. See Table 1 for a summary of the guideline updates.

The guideline uses the WHO definition of severe covid which, in adults, includes clinical signs of pneumonia plus one of the following: respiratory rate >30 breaths/min; severe respiratory distress; or SpO2 <90 percent on room air.5 Plus-circle


Dr. Hickey is EMRA Representative to the Clinical Policies Committee 2019–2021. Dr. Villars is EMRA Representative to the Clinical Policies Committee 2021–2022.

References

  1. Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-887.
  2. Alhazzani W, Evans L, Alshamsi F, et al. Surviving sepsis campaign: guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update. Crit Care Med. 2021;49(3):e219-e234.
  3. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
  4. Moberg J, Oxman AD, Rosenbaum S, et al. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst. 2018;16(1):45.
  5. World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020 (No. WHO/2019-nCoV/clinical/2020.5). New York, NY: World Health Organization; 2020.
  6. Korley FK, Durkalski-Mauldin V, Yeatts SD, et al; SIREN-C3PO Investigators. Early convalescent plasma for high-risk outpatients with Covid-19 [online ahead of print Aug 18]. N Engl J Med. 2021.

Pages: 1 2 | Single Page

Topics: Clinical GuidelineCOVID-19GuidelinesSepsis

Related

  • ACEP Clinical Policy on Thrombolytics for Management of Acute Ischemic Stroke

    July 3, 2025 - 0 Comment
  • Dr. Joe Sachs and “The Pitt” Redefine Public Health Education Through Storytelling

    July 3, 2025 - 0 Comment
  • ACEP Clinical Policy on Outpatient Mgmt. of Adults with Asymptomatic Elevated Blood Pressure

    June 25, 2025 - 0 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

No Responses to “The Surviving Sepsis Campaign Creates COVID-19 Guideline”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603